A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of the current study is to characterize the pharmacokinetic (PK) profile of PF 04958242 when co administered with a strong cytochrome P450 3A4 (CYP3A4) inhibitor.
Key facts
- Study ID
- NCT02341482
- Run by
- Biogen
- People needed
- 13
- Starts
- 2015-02-05
- Expected to finish
- 2015-03-31
- Last updated by the study team
- 2020-01-09
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Pfizer New Haven Clinical Research Unit — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.